Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Serum inflammatory markers as predictors of therapeutic response in non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease: a retrospective cohort analysis

Fig. 2

Mixed model for repeated measures demonstrating FVC% response over time while treated, stratified by initial high vs. low-to-normal inflammatory markers. Fixed effects were FVC%, time on treatment, and inflammatory marker status, with individual patients as random effects. FVC% appears to be improving over time in treated patients with initially high inflammatory markers vs. declining in those with low-to-normal markers (P = 0.003)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us